Katz Michael David M.D. 4
4 · Hanover Bancorp, Inc. /NY · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Katz Michael David M.D.
Director
Transactions
- Award
Common Stock
2023-01-24+1,612→ 144,405 total
Holdings
- 25(indirect: See Footnote 2)
Common Stock
- 96,760(indirect: See Footnote 3)
Common Stock
- 40(indirect: See Footnote 2)
Common Stock
Footnotes (3)
- [F1]Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028.
- [F2]Held as custodian for Dr. Katz's grandchild
- [F3]Held by a trust to which Dr. Katz is a beneficiary